Tag Archives: YTEN

Maxim Group Keeps a Buy Rating on Yield10 Bioscience (YTEN)

In a report released today, Anthony Vendetti from Maxim Group maintained a Buy rating on Yield10 Bioscience (YTEN – Research Report), with a price target of $12.00. The company’s shares closed last Friday at $5.24, close to its 52-week low

National Securities Corp Keeps Their Hold Rating on Yield10 Bioscience (YTEN)

In a report released today, Ben Klieve from National Securities Corp reiterated a Hold rating on Yield10 Bioscience (YTEN – Research Report), with a price target of $10.00. The company’s shares closed last Thursday at $4.84, close to its 52-week

Yield10 Bioscience (YTEN) Gets a Hold Rating from National Securities Corp

National Securities Corp analyst Ben Klieve reiterated a Hold rating on Yield10 Bioscience (YTEN – Research Report) today and set a price target of $10.00. The company’s shares closed last Monday at $4.46, close to its 52-week low of $3.64.

A Major Shareholder at Yield10 Bioscience (NASDAQ: YTEN) is Selling Shares

Yesterday, a Major Shareholder at Yield10 Bioscience (YTEN – Research Report), Jack Schuler, sold shares of YTEN for $550.9K. This is Schuler’s first Sell trade following 4 Buy transactions. See today’s analyst top recommended stocks >> Based on Yield10 Bioscience’s

Maxim Group Sticks to Their Buy Rating for Yield10 Bioscience (YTEN)

In a report released yesterday, Anthony Vendetti from Maxim Group reiterated a Buy rating on Yield10 Bioscience (YTEN – Research Report), with a price target of $0.50. The company’s shares closed last Monday at $0.15, close to its 52-week low

National Securities Corp Keeps a Buy Rating on Yield10 Bioscience Inc (YTEN)

In a report released today, Ben Klieve from National Securities Corp reiterated a Buy rating on Yield10 Bioscience Inc (YTEN – Research Report). The company’s shares closed last Monday at $0.96. According to TipRanks.com, Klieve is a 4-star analyst with